Home / News / TissueGen hires Jennifer Seifert as senior scientist

TissueGen hires Jennifer Seifert as senior scientist

29 Jun '15

2 min read

TissueGen Inc., a developer of cutting-edge absorbable polymer technology for implantable drug delivery, has appointed Dr. Jennifer Seifert, Ph.D., as a senior scientist to lead TissueGen’s application of Elute fibre technology to treat spinal cord injuries and related applications for regenerative medicine.

Seifert joins TissueGen from the University of Texas at Dallas where she held the position of research assistant professor in the department of bioengineering. She has an extensive background in molecular biology and neuroscience and has focused her research career largely upon the development of repair strategies for the central and peripheral nervous systems applying cellular and molecular mechanisms of axonal growth.

As a postdoctoral fellow at University of Texas at Arlington, Seifert established an animal model of distraction spinal cord injury in collaboration with Texas Scottish Rite Hospital. She has also worked on evaluating nerve regeneration through a biosynthetic nerve conduit, establishing a wireless device and protocol for recording somatosensory evoked potentials, and testing the reliability and stability of a regenerative nerve electrode interface, TissueGen informs in a statement.

Seifert holds a Ph.D. in molecular biology from Texas Woman’s University and Bachelor of Science in biology from the University of Texas at Dallas. She was awarded a grant from the Scoliosis Research Society for “Neuroprotection Against Oxidative Stress in an Animal Model of Distraction Spinal Cord Injury.”

TissueGen’s Elute fibres directly replace standard fibres in biodegradable medical textiles and may significantly improve clinical outcomes by delivering therapeutic agents directly at the surgical site. (GK)

Fibre2fashion News Desk - India